8-K
Current Report
CytomX Therapeutics, Inc. Filed Acc 0001564590-17-019886
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ctmx-8k_20171023.htm…